Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$86.58
Market cap
$1.95B
P/E Ratio
50.93
Dividend/share
$0.62
EPS
$1.7
Enterprise value
$1.94B
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops,
Highlights
The EPS has grown by 49% YoY and by 11% from the previous quarter
LMAT's net income is up by 49% year-on-year and by 11% since the previous quarter
The company's debt rose by 10% YoY but it fell by 2.5% QoQ
The P/E is 19% more than the 5-year quarterly average of 42.7 and 14% more than the last 4 quarters average of 44.5
Key stats
What are the main financial stats of LMAT
Market
Valuations
Earnings
Shares outstanding
22.47M
Market cap
$1.95B
Enterprise value
$1.94B
Price to earnings (P/E)
50.93
Price to book (P/B)
6.08
Price to sales (P/S)
9.46
EV/EBIT
39.27
EV/EBITDA
32.88
EV/Sales
9.44
Revenue
$205.62M
EBIT
$49.44M
EBITDA
$59.05M
Free cash flow
$31.69M
Per share
Balance sheet
Liquidity
EPS
$1.7
Free cash flow per share
$1.41
Book value per share
$14.24
Revenue per share
$9.16
TBVPS
$11.5
Total assets
$363.08M
Total liabilities
$43.55M
Debt
$18.41M
Equity
$319.53M
Working capital
$187.37M
Debt to equity
0.06
Current ratio
8.36
Quick ratio
5.66
Net debt/EBITDA
-0.07
Margins
Efficiency
Dividend
EBITDA margin
28.7%
Gross margin
67.7%
Net margin
18.3%
Operating margin
22.2%
Return on assets
10.8%
Return on equity
12.4%
Return on invested capital
23.5%
Return on capital employed
14.6%
Return on sales
24%
Dividend yield
0.72%
DPS
$0.62
Payout ratio
36.5%
LMAT stock price
How has the Lemaitre Vascular stock price performed over time
Intraday
-0.45%
1 week
-3.47%
1 month
-4.99%
1 year
74.84%
YTD
52.54%
QTD
-6.79%
Financial performance
How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$205.62M
Gross profit
$139.21M
Operating income
$45.64M
Net income
$37.68M
Gross margin
67.7%
Net margin
18.3%
The operating income has grown by 50% YoY and by 12% from the previous quarter
LMAT's net income is up by 49% year-on-year and by 11% since the previous quarter
The company's net margin rose by 29% YoY and by 8% QoQ
The company's operating margin rose by 29% YoY and by 9% QoQ
Growth
What is Lemaitre Vascular's growth rate over time
Valuation
What is Lemaitre Vascular stock price valuation
P/E
50.93
P/B
6.08
P/S
9.46
EV/EBIT
39.27
EV/EBITDA
32.88
EV/Sales
9.44
The EPS has grown by 49% YoY and by 11% from the previous quarter
The P/E is 19% more than the 5-year quarterly average of 42.7 and 14% more than the last 4 quarters average of 44.5
LMAT's price to book (P/B) is 35% higher than its 5-year quarterly average of 4.5 and 27% higher than its last 4 quarters average of 4.8
The equity has grown by 13% YoY and by 3.6% from the previous quarter
The P/S is 41% above the 5-year quarterly average of 6.7 and 28% above the last 4 quarters average of 7.4
Lemaitre Vascular's revenue has increased by 16% YoY and by 2.9% from the previous quarter
Efficiency
How efficient is Lemaitre Vascular business performance
Lemaitre Vascular's return on assets has increased by 35% YoY and by 8% QoQ
The ROE has grown by 33% YoY and by 8% from the previous quarter
The ROS has grown by 32% YoY and by 9% from the previous quarter
LMAT's ROIC is up by 28% year-on-year and by 6% since the previous quarter
Dividends
What is LMAT's dividend history
DPS
$0.62
Dividend yield
0.72%
Payout ratio
36.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Lemaitre Vascular financials performed over time
LMAT's quick ratio is up by 25% YoY and by 9% QoQ
Lemaitre Vascular's current ratio has increased by 24% YoY and by 10% from the previous quarter
The company's debt is 94% lower than its equity
The equity has grown by 13% YoY and by 3.6% from the previous quarter
The company's debt rose by 10% YoY but it fell by 2.5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.